JP2014505254A - 診断方法 - Google Patents

診断方法 Download PDF

Info

Publication number
JP2014505254A
JP2014505254A JP2013550945A JP2013550945A JP2014505254A JP 2014505254 A JP2014505254 A JP 2014505254A JP 2013550945 A JP2013550945 A JP 2013550945A JP 2013550945 A JP2013550945 A JP 2013550945A JP 2014505254 A JP2014505254 A JP 2014505254A
Authority
JP
Japan
Prior art keywords
level
sample
compound
determining
liver cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2013550945A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014505254A5 (enExample
Inventor
サイモン ディー． テイラー−ロビンソン，
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ip2ipo Innovations Ltd
Original Assignee
Imperial Innovations Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial Innovations Ltd filed Critical Imperial Innovations Ltd
Publication of JP2014505254A publication Critical patent/JP2014505254A/ja
Publication of JP2014505254A5 publication Critical patent/JP2014505254A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • G01N33/57525—
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57438—Specifically defined cancers of liver, pancreas or kidney
    • G01N33/575—
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6806—Determination of free amino acids
    • G01N33/6812—Assays for specific amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/08—Hepato-biliairy disorders other than hepatitis
    • G01N2800/085—Liver diseases, e.g. portal hypertension, fibrosis, cirrhosis, bilirubin
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/17—Nitrogen containing
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/17—Nitrogen containing
    • Y10T436/173845—Amine and quaternary ammonium
    • Y10T436/174614—Tertiary amine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/20—Oxygen containing
    • Y10T436/200833—Carbonyl, ether, aldehyde or ketone containing
    • Y10T436/201666—Carboxylic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
JP2013550945A 2011-01-31 2012-01-31 診断方法 Pending JP2014505254A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1101667.2 2011-01-31
GBGB1101667.2A GB201101667D0 (en) 2011-01-31 2011-01-31 Diagnostic method
PCT/GB2012/000100 WO2012104585A2 (en) 2011-01-31 2012-01-31 Diagnostic method

Publications (2)

Publication Number Publication Date
JP2014505254A true JP2014505254A (ja) 2014-02-27
JP2014505254A5 JP2014505254A5 (enExample) 2015-03-12

Family

ID=43824891

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013550945A Pending JP2014505254A (ja) 2011-01-31 2012-01-31 診断方法

Country Status (9)

Country Link
US (1) US20140134751A1 (enExample)
EP (1) EP2671077A2 (enExample)
JP (1) JP2014505254A (enExample)
KR (1) KR20140007414A (enExample)
CN (1) CN103430022A (enExample)
AP (1) AP2013007084A0 (enExample)
AU (1) AU2012213244A1 (enExample)
GB (1) GB201101667D0 (enExample)
WO (1) WO2012104585A2 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2019184257A (ja) * 2018-04-02 2019-10-24 味の素株式会社 胃癌の評価方法、算出方法、評価装置、算出装置、評価プログラム、算出プログラム、記録媒体、評価システム、及び端末装置

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201307256D0 (en) * 2013-04-22 2013-05-29 Imp Innovations Ltd Diagnostic method
CN111638324B (zh) * 2020-05-28 2023-08-11 长沙都正生物科技有限责任公司 一种冠心病诊断生物标记物组合及其应用
GB202102105D0 (en) * 2021-02-15 2021-03-31 Novabiotics Ltd Prognostic method
CN114414611B (zh) * 2022-01-25 2025-07-15 嘉兴大学 一种肝癌微血管侵犯鉴别模型的构建方法及肝癌微血管侵犯预测值的测试方法
WO2025008463A1 (en) 2023-07-06 2025-01-09 Numares Ag Use of a marker set for determining the risk of an individual to have hepatocellular carcinoma
KR102881746B1 (ko) * 2024-04-19 2025-11-06 주식회사 티엠에이오 인체내 트리메틸아민-n-옥사이드(tmao) 진단을 위한 키트 및 항체의 이용

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070015146A1 (en) * 2001-05-22 2007-01-18 Gene Logic, Inc. Molecular nephrotoxicology modeling
CN1197973C (zh) * 2001-12-27 2005-04-20 张抗 肝癌诊断、监护及肝硬化监护试剂盒
AU2003255643A1 (en) * 2003-06-05 2005-01-21 Vincent Thomas Armbruster Measuring system for measuring at least one characteristic of a biological tissue and method for fixing a biological tissue to a measuring system of this type
US7373256B2 (en) * 2005-04-19 2008-05-13 Nicholson Jeremy K Method for the identification of molecules and biomarkers using chemical, biochemical and biological data
CN101464271A (zh) * 2007-12-19 2009-06-24 苏州艾杰生物科技有限公司 甘氨酸诊断/测定试剂盒及甘氨酸的浓度测定方法

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
JPN5014003625; Ｚｏｎｇ-Ｆａｎｇ　Ｌｉ，　Ｊｕａｎ　Ｗａｎｇ，　Ｃｈｅｎ　Ｈｕａｎｇ，　ｅｔ　ａｌ．: 'Ｇａｓ　ｃｈｒｏｍａｔｏｇｒａｐｈｙ／ｔｉｍｅ-ｏｆ-ｆｌｉｇｈｔ　ｍａｓｓ　ｓｐｅｃｔｒｏｍｅｔｒｙ-ｂａｓｅｄ　ｍｅｔａｂｏｎｏｍｉｃｓ　ｏｆ　ｈｅｐａｔｏｃａｒｃｉｎｏｍａ　ｉｎ　ｒａｔｓ　ｗｉ' Ｐａｐｉｄ　ｃｏｍｍｕｎｉｃａｔｉｏｎ　ｉｎ　ｍａｓｓ　ｓｐｅｃｔｒｏｍｅｔｒｙ Ｖ２４　Ｎ１８, 201009, Ｐ２７６５-２７７５ *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2019184257A (ja) * 2018-04-02 2019-10-24 味の素株式会社 胃癌の評価方法、算出方法、評価装置、算出装置、評価プログラム、算出プログラム、記録媒体、評価システム、及び端末装置
JP7230335B2 (ja) 2018-04-02 2023-03-01 味の素株式会社 取得方法、算出方法、評価装置、算出装置、評価プログラム、算出プログラム、記録媒体、及び評価システム

Also Published As

Publication number Publication date
WO2012104585A2 (en) 2012-08-09
CN103430022A (zh) 2013-12-04
AP2013007084A0 (en) 2013-08-31
AU2012213244A1 (en) 2013-09-05
GB201101667D0 (en) 2011-03-16
EP2671077A2 (en) 2013-12-11
KR20140007414A (ko) 2014-01-17
US20140134751A1 (en) 2014-05-15
WO2012104585A3 (en) 2012-12-27

Similar Documents

Publication Publication Date Title
Dinges et al. Cancer metabolomic markers in urine: evidence, techniques and recommendations
Srivastava et al. Taurine–a possible fingerprint biomarker in non-muscle invasive bladder cancer: a pilot study by 1H NMR spectroscopy
Pérez-Rambla et al. Non-invasive urinary metabolomic profiling discriminates prostate cancer from benign prostatic hyperplasia
Gowda et al. Metabolomics-based methods for early disease diagnostics
US8653006B2 (en) Metabolite biomarkers for the detection of esophageal cancer using NMR
JP2014505254A (ja) 診断方法
Tian et al. Wang Y
JP6692422B2 (ja) 尿中代謝物による疾病診断法
Eisner et al. Learning to predict cancer-associated skeletal muscle wasting from 1H-NMR profiles of urinary metabolites
US20100173346A1 (en) Methods for detecting coronary artery disease
AU2011260390A1 (en) Means and methods for diagnosing pancreatic cancer in a subject
US20110123976A1 (en) Biomarkers and identification methods for the early detection and recurrence prediction of breast cancer using NMR
RU2666255C2 (ru) Метилглиоксаль в качестве маркера злокачественной опухоли
AU2012343843A1 (en) Device and methods to diagnose pancreatic cancer
CN101443663A (zh) 诊断糖尿病的工具和方法
US20170023575A1 (en) Identification of blood based metabolite biomarkers of pancreatic cancer
CN114441760A (zh) 一种用于肝癌诊断的生物标志物和试剂盒及检测方法
Roberts et al. Seminal plasma enables selection and monitoring of active surveillance candidates using nuclear magnetic resonance-based metabolomics: A preliminary investigation
Dasgupta et al. Discovery of novel metabolic signatures for early identification of women at risk of developing gestational hypertension
EP4414709A1 (en) Diagnostic biomarker for cancer and use thereof
US8133736B2 (en) Methods for detecting or monitoring cancer using LPE as a marker
US20160091494A1 (en) Diagnostic method for hepatic cancer
JP7226732B2 (ja) 尿中腫瘍マーカーによるがん検出方法、キット及び装置
Li et al. Serum metabolomic analysis of human upper urinary tract urothelial carcinoma
Funai et al. Urinary fluorescent metabolite O-aminohippuric acid is a useful biomarker for lung cancer detection

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20131225

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20131225

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150122

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20150122

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20151116

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20151203

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20160302

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20160531